---
title: "KK Shah Hospitals Ltd (544013) — Share Price, Financials & Analysis"
symbol: "544013"
company: "KK Shah Hospitals Ltd"
canonical: "https://tapetide.com/stocks/544013"
isin: "INE0OH401016"
nse_symbol: "KKSHLLTD"
bse_code: "544013"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 29.3
generated_at: "2026-09-13T19:16:44.714Z"
---

# KK Shah Hospitals Ltd (544013)

Canonical page: https://tapetide.com/stocks/544013

## Company

- **NSE Symbol:** KKSHLLTD
- **BSE Code:** 544013
- **ISIN:** INE0OH401016
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2023-11-06
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** shahhospitalratlam.com

## About

Incorporated in 2022, KK Shah Hospitals Ltd offers multi-speciality healthcare services.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:34:49.764448Z.

- **Market Cap:** ₹29.3 Cr
- **Classification:** SME
- **P/E (reported):** -47.3
- **EPS (reported):** ₹0.89
- **Book Value:** ₹18.79
- **Price to Book:** 2.29
- **Dividend Yield:** 1.16%
- **ROE:** -4.87%
- **ROCE:** -5.69%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹9.6 Cr
- **Net Income:** ₹-0.6 Cr
- **EBITDA:** ₹1 Cr
- **52-Week High:** ₹51.9
- **52-Week Low:** ₹29
- **RSI (14):** 16.94

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Company has low interest coverage ratio.
- Company has a low return on equity of -0.93% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -69.33% | 218.97% | 213.64% |
| ebitda margin growth | 50% | 38.3% | -32.13% | -55.69% |
| net income growth | 100% | 100% | -200% | -400% |
| revenue growth | 18.75% | 0% | 64% | 51.57% |
| roce | — | 134.16% | -214.95% | 1.35% |
| roe | — | 99.59% | -1% | -255.1% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2.12 | 3.39 | 3.49 | 4.03 | 4.97 | 4.82 | 4.61 |
| Expenses | 1.75 | 3.01 | 3.27 | 3.7 | 5.18 | 4.17 | 4.49 |
| Operating Profit | 0.37 | 0.38 | 0.22 | 0.33 | -0.21 | 0.65 | 0.12 |
| OPM % | 17.45 | 11.21 | 6.3 | 8.19 | -4.23 | 13.49 | 2.6 |
| Other Income | 0.02 | 0.13 | 0.35 | 0.18 | 0.38 | 0.04 | 0.15 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.1 | 0.19 | 0.19 | 0.35 | 0.66 | 0.91 | 0.78 |
| Profit before tax | 0.29 | 0.32 | 0.38 | 0.16 | -0.49 | -0.22 | -0.51 |
| Tax % | 24.14 | 25 | 2.63 | -131.25 | 44.9 | 45.45 | -41.18 |
| Net Profit | 0.22 | 0.24 | 0.37 | 0.37 | -0.7 | -0.32 | -0.3 |
| EPS in Rs | 0.45 | 0.49 | 0.54 | 0.54 | -1.03 | -0.47 | -0.44 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 2.11 | 6.79 | 8.73 | 9.31 |
| Expenses | 1.74 | 6.19 | 8.6 | 8.54 |
| Operating Profit | 0.37 | 0.6 | 0.13 | 0.77 |
| OPM % | 17.54 | 8.84 | 1.49 | 8.27 |
| Other Income | 0.02 | 0.48 | 0.56 | 0.19 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0.1 | 0.38 | 1.01 | 1.68 |
| Profit before tax | 0.29 | 0.7 | -0.32 | -0.72 |
| Tax % | 24.14 | 12.86 | 0 | -15.28 |
| Net Profit | 0.22 | 0.61 | -0.33 | -0.62 |
| EPS in Rs | 0.45 | 0.9 | -0.48 | -0.91 |
| Dividend Payout % | 0 | 55.82 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Equity Capital | 4.86 | 6.81 | 6.81 | 6.81 |
| Reserves | 0.23 | 7.28 | 6.61 | 5.98 |
| Borrowings | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.52 | 0.54 | 2.56 | 2.23 |
| Total Liabilities | 5.61 | 14.63 | 15.98 | 15.02 |
| Fixed Assets | 1.29 | 1.27 | 7.81 | 6.49 |
| CWIP | 0 | 0.62 | 0 | 6.22 |
| Investments | 2.02 | 10.45 | 6.5 | 0.56 |
| Other Assets | 2.3 | 2.29 | 1.67 | 1.75 |
| Total Assets | 5.61 | 14.63 | 15.98 | 15.02 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.55 | -0.58 | 2.25 | 0.69 |
| Cash from Investing Activity | -3.4 | -9.02 | -2.35 | -0.6 |
| Cash from Financing Activity | 4.87 | 8.39 | -0.34 | 0 |
| Net Cash Flow | 2.02 | -1.21 | -0.44 | 0.09 |
| Free Cash Flow | -0.84 | -1.56 | -4.67 | -5.9 |
| CFO/OP | 149 | -83 | 1885 | 90 |

### Ratios

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Debtor Days | 8.65 | 5.91 | 2.51 | 20.39 |
| Cash Conversion Cycle | 8.65 | 5.91 | 2.51 | 20.39 |
| Working Capital Days | -41.52 | 38.7 | -58.53 | -49.01 |
| ROCE % | — | 7.3 | -2.33 | -5.49 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Promoters | 100% | 71.36% | 71.36% | 71.36% | 71.36% | 71.36% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 24.9% | 25.38% | 24.54% | 24.98% | 24.67% |
| Others | 0% | 3.75% | 3.26% | 4.1% | 3.66% | 3.97% |
| No. of Shareholders | 7 | 418 | 420 | 392 | 377 | 362 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 7 / 7 / 5

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 41.99 | Buy |
| EMA (10) | 42.17 | Buy |
| SMA (20) | 41.17 | Buy |
| EMA (20) | 42.48 | Buy |
| SMA (50) | 41.15 | Buy |
| EMA (50) | 49.61 | Sell |
| SMA (100) | 59.41 | Sell |
| EMA (100) | 53.92 | Sell |
| SMA (200) | 51.59 | Sell |
| EMA (200) | 55.12 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 48.87 | Neutral |
| MACD (12,26,9) | -1.62 | Buy |
| Stochastic (14,3,3) | 54.8 | Neutral |
| ADX (14) | 10.81 | Neutral |
| Williams %R (14) | -41.91 | Neutral |
| ATR (14) | 3.74 | High Volatility |
| ROC (12) | 7.5 | Buy |
| Stoch RSI (14) | 70.09 | Neutral |
| UO (7,14,28) | 55.72 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-19 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdeda374-d609-4e65-9b6c-370c1c3ae32e.pdf) |
| 2026-08-18 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a800dea7-1577-48e7-8299-6daceca70774.pdf) |
| 2026-07-25 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e84ac6fd-80a1-4d5f-abe2-82b96e059a33.pdf) |
| 2026-07-25 | [Notice Of Shareholder Meeting On August 18 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec709ce0-92f4-4d2e-a114-eecf4eced55b.pdf) |
| 2026-07-24 | [Board Meeting Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10843454-6bc0-4ee8-b22d-4920a198875a.pdf) |
| 2026-07-13 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cf8ea65-27b3-4008-8b0a-e6ea40fde7a8.pdf) |
| 2026-07-01 | [Installation And Commissioning Of GE Revolution Evo 64-Slice Cardiac CT Scanner.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa96f298-bf2f-4875-958c-52a0ff1a0999.pdf) |
| 2026-05-18 | [Board Meeting Outcome for Board Meeting Outcome For For Approval Of Financial Result For 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d9ff06f-4e57-407f-b8a3-fa66dbead392.pdf) |
| 2026-05-11 | [Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a28677a-ce54-48bd-83d7-3e50dc59a430.pdf) |
| 2026-04-13 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9297b526-9774-4a37-950d-907e0db7c741.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-18 | [Result - Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f59c217e-bed1-4417-997f-833dfd9db313.pdf) |
| 2025-11-10 | [Financial Results For The Half Year Ended As On 30Th September 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30a88686-9da0-456c-8dd4-5ce11429b2a8.pdf) |
| 2025-05-27 | [Financial Result As On 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09d149c9-b5dc-404b-9e98-9d6d34f2d83b.pdf) |
| 2024-11-12 | [Results (Financial Result For The Half Year Ended On 30Th September 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=765d40cb-02ca-4a9a-b1f4-40a81f36f646.pdf) |
| 2024-05-28 | [Audited Financial Result For F.Y. 2023-24](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e0ff815-b29f-464d-b6cf-dd72c9b7540c.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 March 2026 - RNFI: RNFI Services Limited has informed about Updates on Incorporation | [Incorporation 9 March 2026 - RNFI: RNFI Services Limited has informed about Updates on Incorporation](https://nsearchives.nseindia.com/corporate/RNFI_09032026142356_Intimation_Investment_in_WOS_.pdf) |
| 9 Mar - KK Shah Hospitals empanelled under Ayushman Bharat on 09-03-2026 to serve scheme beneficiaries. | [Announcement Under Regulation 30 SEBI (LODR)Empanelment With Ayushman Bharat Pradhan Mantri Jan Arogya Yojana 9 Mar - KK Shah Hospitals empanelled under Ayushman Bharat on 09-03-2026 to serve scheme beneficiaries.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8271c228-5bba-4b49-968a-4f14603a941b.pdf) |
| 2 March 2026 - RNFI Money empaneled with Canara Bank for 2026 foreign currency transactions; holds RBI AD-II license. | [General Updates 2 March 2026 - RNFI Money empaneled with Canara Bank for 2026 foreign currency transactions; holds RBI AD-II license.](https://nsearchives.nseindia.com/corporate/RNFI_02032026161914_Intimation.pdf) |
| 18 February 2026 - Q3 FY26 earnings conference call transcript dated Feb 13, 2026 hosted online. | [Analysts/Institutional Investor Meet/Con. Call Updates 18 February 2026 - Q3 FY26 earnings conference call transcript dated Feb 13, 2026 hosted online.](https://nsearchives.nseindia.com/corporate/RNFI_18022026183826_NSE.pdf) |
| 17h - Board meeting on 18 May 2026 to approve audited FY2025-26 standalone results; trading window closed till 48 hours post-results. | [Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Year Ended March 31, 2026 17h - Board meeting on 18 May 2026 to approve audited FY2025-26 standalone results; trading window closed till 48 hours post-results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2a28677a-ce54-48bd-83d7-3e50dc59a430.pdf) |
| 13 Jan - Empanelled with Railway Hospital (Western Railway), Ratlam to provide medical services; dated 13-01-2026. | [Announcement Under Regulation 30 SEBI (LODR) Empanelment With Railways Hospital (Western Railway), Ratlam. 13 Jan - Empanelled with Railway Hospital (Western Railway), Ratlam to provide medical services; dated 13-01-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b5d55dc-e162-425d-85dd-704e35107bf0.pdf) |
| 13 February 2026 - Video recording of RNFI Q3 FY26 earnings call (13-Feb-2026) available on company website. | [Analysts/Institutional Investor Meet/Con. Call Updates 13 February 2026 - Video recording of RNFI Q3 FY26 earnings call (13-Feb-2026) available on company website.](https://nsearchives.nseindia.com/corporate/RNFI_13022026181458_RNFI_15112025122448_Intimation_of_video_recording_2.pdf) |
| 13 Apr - Compliances Certificate Under Regulation 74(5) of SEBI (DP) Regulation, 2018 for the Quarter Ended 31st March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Apr - Compliances Certificate Under Regulation 74(5) of SEBI (DP) Regulation, 2018 for the Quarter Ended 31st March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9297b526-9774-4a37-950d-907e0db7c741.pdf) |
| 11 February 2026 - Filed Q3 & 9M FY26 earnings presentation; 9M revenue ₹729.3 Cr, PAT ₹24.1 Cr. | [Investor Presentation 11 February 2026 - Filed Q3 & 9M FY26 earnings presentation; 9M revenue ₹729.3 Cr, PAT ₹24.1 Cr.](https://nsearchives.nseindia.com/corporate/RNFI_11022026124132_Investor_Presentation.pdf) |
| 11 February 2026 - Extract of unaudited standalone and consolidated Q3 and nine-month results for period ended Dec 31, 2025. | [Copy of Newspaper Publication 11 February 2026 - Extract of unaudited standalone and consolidated Q3 and nine-month results for period ended Dec 31, 2025.](https://nsearchives.nseindia.com/corporate/RNFI_11022026124505_Newspaper_Advertisement.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28897_RNFI_2024_2025_A_15407690_08092025150320.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25826_RNFI_2023_2024_05092024165153.pdf) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e84ac6fd-80a1-4d5f-abe2-82b96e059a33.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b6513ad1-65b4-465f-969c-b9f7848d3eb5.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/db1ce2a8-4ccc-4f9a-970b-e54d569f0d7a.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/RNFI_13112025200954_investor_ppt.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/RNFI_19112025185150_Transcript_RNFI__14_11.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://nsearchives.nseindia.com/corporate/RNFI_12112024182955_Investor.pdf) |
| May 2025 | [Concall - May 2025](https://nsearchives.nseindia.com/corporate/RNFI_28052025145344_Investor_Presentation_with_Covering_Letter.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://nsearchives.nseindia.com/corporate/RNFI_05062025194732_NSE_IntimationTranscript30052025.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:16:44.714Z.